Skip to main content

Table 4 Predictive factors for in-hospital death within 14 days afteradmission

From: Age-related differences in symptoms, diagnosis and prognosis of bacteremia

 

Alive at 14 days(608 patients;% within thisgroup)

Patients that died within 14 days(72 patients;%within this group)

Bivariate analyses OR(95% CI)

Multivariate analysis; full main effectsmodel*OR(95%CI)

Age ≥ 65 years

386 (63.5)

66 (91.7)

6.33 (2.70 - 14.83)

15.02 (3.68 - 61.29)

Male gender

246 (40.5)

43 (59.7)

2.18 (1.33 - 3.59)

1.93 (1.002 - 3.70)

S. pneumoniae

196 (32.2)

34 (47.2)

1.88 (1.15 - 3.08)

2.79 (1.43 - 5.46)

Comorbid illnesses ≥ 1

355 (58.1)

59 (81.9)

3.27 (1.76 – 6.09)

2.61 (1.11 - 6.14)

Immunmodulating and other medication

    

  Warfarin

51 (8.5)

5 (7.0)

0.82 (0.32 - 2.12)

 

  Corticosteroids1 on a daily basis

28 (4.7)

6 (8.5)

1.89 (0.75 - 4.73)

 

  Cytostatic treatment within last 14 days

5 (0.8)

2 (2.8)

3.46 (0.66 - 18.15)

 

  Immunosuppressive drugs

6 (1.0)

1 (1.4)

1.42 (0.17 - 11.94)

 

Number of symptoms

    

  Number of symptoms ≥ 5

69 (11.4)

8 (11.3)

0.99 (0.45 – 2.15)

 

  “Classical symptoms”2≥ 3

236 (39.0)

17 (23.9)

0.49 (0.28 – 0.87)

 

  “Atypical symptoms”3 ≥1

296 (48.4)

44 (61.1)

1.67 (1.02 – 2.76)

 

Prehospital tentative diagnosis

    

Infection

303 (49.6)

28 (38.9)

0.65 (0.39 – 1.07)

 

Non-specifica

81 (13.3)

8 (11.1)

0.82 (0.38 – 1.77)

 

Site of infection

    

  Urinary tractus

241 (39.6)

14 (19.4)

0.37 (0.20 - 0.67)

 

  Lower respiratory tractus

193 (31.7)

35 (48.6)

2.03 (1.24 - 3.33)

 

  Othersb

95 (15.6%)

12 (16.7%)

1.08 (0.56 – 2.08)

 

  Inconclusive

79 (13.0)

11 (15.3)

1.21 (0.61 - 2.39)

 

Local immunocompromizing condition (at site of infection)

    

Significant anatomical or physiological abnormality

206 (38.9)

17 (27.9)

0.61 (0.34 - 1.09)

 

  Surgical procedure performed within 14 days priorto admittance

54 (8.9)

1 (1.4)

0.15 (0.02 - 1.11)

 

Signs of infection in the emergency department

    

  Fever (≥ 38.5°C)

402 (67.2)

36 (52.9)

0.55 (0.33 - 0.91)

0.46 (0.24 - 0.89)

  Hypothermia (< 36 ° C)

7 (1.2)

3 (4.2)

3.90 (0.98 – 15.44)

 

  Tachycardia

383 (63.6)

44 (63.8)

1.01 (0.60 – 1.69)

 

  Tachypnoe and/or hyperventilation

215 (35.3)

40 (55.6)

2.29 (1.40 - 3.75)

 

  Leukocytosis (≥ 15000/μl)

255 (41.9)

25 (35.2)

0.75 (0.45 – 1.26)

 

  Leukopenia (< 3000/μl)

21 (3.5)

16 (22.5)

8.13 (4.01 - 16.49)

4.62 (1.88 - 11.37)

  CRP ≥ 80 mg/L

457 (75.2)

57 (79.2)

1.26 (0.69 – 2.28)

 

  CRP ≥ 200 mg/L

280 (46.1)

44 (61.1)

1.84 (1.12 – 3.04)

 

  Decline in general health

244 (40.2)

45 (62.5)

2.48 (1.50 - 4.10)

 

  New-onset atrial fibrillation

84 (14.0)

20 (28.2)

2.41 (1.37 - 4.25)

 

Number of failing organs within one day after admission

-

-

3.25 (2.48 - 4.26)

3.06 (2.2 - 4.27)

  1. OR = odds ratio, CI = confidence interval.1Equivalent toprednisolone ≥ 10 mg per day2“Classical symptoms”: fever/chills, localizedpain, nausea/vomiting, diarrhea, cough, dyspnea, expectoration, urgency,painful voiding, hematuria; skin rash and coma/seizures,3“Atypical symptoms”: Malaise, falls, dizziness,syncope, unsteadiness, immobility, acute urinary or fecal incontinence,paresis/speaking difficulties, acute confusional stateaincluding delirium and acute deterioration in the ability toperform daily tasks bgastrointestinal tract, liver, pancreasand biliary tract.
  2. *Interaction analyses indicated that high age significantly increased theeffect of type of bacterium on hospital mortality (results notshown).